Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection

Harmony L. Tyner; Mark G. Thompson; Jefferey L. Burgess; Lauren Grant; Manjusha Gaglani; Jennifer L. Kuntz; Allison L. Naleway; Natalie J. Thornburg; Alberto J. Caban-Martinez; Sarang K. Yoon; Meghan K. Herring; Shawn C. Beitel; Lenee Blanton; Janko Nikolich-Zugich; Matthew S. Thiese; Jessica Flores Pleasants; Ashley L. Fowlkes; Karen Lutrick; Kayan Dunnigan; Young M. Yoo; Spencer Rose; Holly Groom; Jennifer Meece; Meredith G. Wesley; Natasha Schaefer-Solle; Paola Louzado-Feliciano; Laura J. Edwards; Lauren E. W. Olsho.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21265171